Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90
(-0.92%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy's Lab - Quaterly Results
>>
Dr. Reddy’s completes full set of clinical studies of rituximab biosimilar for filing in U.S., Europe
>>
Dr. Reddy’s Laboratories informs about press release
>>
Dr Reddy's reduces price of cardiovascular drug ‘Cidmus’
>>
Dr. Reddy’s acquires trademark rights of breast cancer drug PRIMCYV from Pfizer Products
>>
Dr. Reddy's inks pact with Theranica
>>
Dr. Reddy’s Laboratories informs about disclosure
>>
Dr. Reddy's Laboratories completes Phase 1 study of proposed biosimilar of Tocilizumab
>>
Dr.Reddy's Laboratories informs about press release
>>
Dr. Reddy's Laboratories’ arm enters into agreement to sell certain assets, liabilities
<<
<
23
24
25
...141
>
>>